CRISPR news - the latest news from Labiotech.eu

Home CRISPR Page 9

Latest Posts

Partnerships Cover

Interview 6 May 2019

2019 Will Be a “Year of Realism” for Biotech Investments

Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At BIO-Europe Spring 2019, Regina Hodits, Managing Partner at German VC firm Wellington Partners Life Sciences, spoke to us about the firm’s realistic approach to biotech investment. Biotechnology is an industry with high risks and high rewards. Before a medical biotech […]

May 6, 2019 - 6 minutesmins - By Jonathan Smith

crispr cas9 cassava crop virus resistance

News and Trends 29 Apr 2019

Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants

Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the bacterial weapon CRISPR-Cas9, which could have major regulatory implications. Geminiviruses are pathogens that kill off crops such as beans, cotton and cassava plants. Past efforts to breed plants that are resistant to infection have not been successful. One potential method […]

April 29, 2019 - 2 minutesmins - By Jonathan Smith

Francis Mojica CRISPR interview

Interview 8 Apr 2019

Francis Mojica, the Spanish Scientist Who Discovered CRISPR

Contrary to popular belief, Francis Mojica was the first person to discover the CRISPR mechanism and give it its name. He told me how the discovery came about, discussed the wide potential of the gene editing tool and shared his favorite CRISPR application. You’ve likely heard of CRISPR/Cas9, a gene editing tool that has taken […]

April 8, 2019 - 11 minutesmins - By Clara Rodríguez Fernández

SNIPR bio story Bacterial cell

News and Trends 11 Mar 2019

Danish Biotech to Develop CRISPR-Based Microbiome Treatments

SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target ‘bad’ bacteria using CRISPR gene editing, while keeping the rest of the patient’s microbiome intact. Founded with €2.6M seed investment from the Lundbeck Foundation in 2017, SNIPR Biome was the first exploratory investment for the Danish organisation’s Emerge fund, which […]

March 11, 2019 - 2 minutesmins - By Helen Albert

CRISPR Cas9 antimicrobial peptide antibiotic resistance

News and Trends 26 Feb 2019

Swiss Scientists Find ‘Silver Bullet’ Against Bacterial Infections

Using the gene editing tool CRISPR-Cas9, researchers in Lausanne have uncovered antimicrobial molecules in the fruit fly that can selectively kill certain bacteria. This could lead to new therapeutics combatting antimicrobial resistance, and even preventing infections before they start. The research shows the antimicrobial molecules, or peptides, have the potential to treat infections of pathogens […]

February 26, 2019 - 3 minutesmins - By Jonathan Smith

CRISPR patents

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s intellectual property, how difficult is it for third parties to access this coveted technology? The CRISPR patent dispute is quite unique. While universities usually work together to disseminate innovation and knowledge, in the CRISPR case […]

February 11, 2019 - 5 minutesmins - By Timothé Cynober

ADVERTISEMENT

CRISPR Cas9 bacteriophage anti CRISPR gut microbiome 1

News and Trends 8 Feb 2019

Anti-CRISPR Proteins Could Improve Gene Editing Precision

A research group in Denmark has found proteins in gut and soil microbes that can inhibit the action of CRISPR-Cas9 gene editing, a finding that could help to control the technology with more precision and less risk. Bacteria and viruses have fought an evolutionary arms race for millions of years. Bacteria evolved CRISPR systems to […]

February 8, 2019 - 3 minutesmins - By Jonathan Smith

CRISPR wageningen netherlands gluten wheat

News and Trends 31 Jan 2019

CRISPR Gene Editing Could Make Gluten Safe for Celiacs

A Dutch research group is using the gene editing tool CRISPR-Cas9 to modify wheat gluten, letting people with celiac disease eat gluten without experiencing debilitating symptoms. In celiac disease, the immune system attacks gluten, causing damage to the intestine. This forces sufferers to stick to expensive gluten-free versions of foods such as bread, which […]

January 31, 2019 - 3 minutesmins - By Jonathan Smith

news roundup biotech crispr

Best in Biotech 31 Dec 2018

European Biotech’s Biggest News of 2018

With this year coming to a close, it’s now time to look back at the biggest biotech news stories of 2018 in Europe, which include CRISPR-Cas9 controversy, big financial deals, and spider silk airplanes. The year 2018 brought a lot of change to the biotech industry in Europe, with clinical trials, approvals and Brexit […]

December 31, 2018 - 12 minutesmins - By Jonathan Smith

christmas tree CRISPR Cas9

News and Trends 19 Dec 2018

Could We Use CRISPR to Light up Future Christmas Trees?

Scientists in the UK have proposed a way to make bioluminescent Christmas trees using the gene editing tool CRISPR-Cas9. CRISPR-Cas9 is a revolutionary gene editing tool that makes it easier to edit the genome. For this reason, it is now a standard tool in research and development centers worldwide, and companies such as the German chemical […]

December 19, 2018 - 2 minutesmins - By Jonathan Smith

BASF Broad institute CRISPR 1

News and Trends 26 Oct 2018

BASF Will Use CRISPR to Gene-Edit Crops and Microbes

The German chemical giant BASF has obtained a non-exclusive license from the US Broad Institute for the use of CRISPR-Cpf1 gene-editing technology in agricultural and microbiological applications. CRISPR-Cas9 is a fast and easy technique for editing the genome that has gained worldwide fame. It has the potential for use in many applications such as in […]

October 26, 2018 - 3 minutesmins - By Jonathan Smith

crispr ers genomics enzyme header

News and Trends 17 Oct 2018

Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR

Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement with ERS Genomics, which licenses out CRISPR intellectual property in the EU. CRISPR technology is a hot topic in the biotech industry because it makes gene editing faster and easier than other techniques. This could make it very useful in […]

October 17, 2018 - 2 minutesmins - By Jonathan Smith

ADVERTISEMENT